Dorsey Wright Healthcare Tech Leaders TR Share Price

Index

Market Closed - Nasdaq 02:46:07 03/07/2024 am IST			5-day change	1st Jan Change
3,044 ^PTS	-0.96%		-1.19%	+8.90%

Current month	-0.92%
1 month	+1.77%

Duration

Period

Style

Goldman Sachs Adjusts Price Target on Eli Lilly & Co. to $793 From $785, Maintains Neutral Rating LLY	03:11pm	MT
Jefferies Adjusts Price Target on Eli Lilly & Co. to $1,041 From $1,015, Maintains Buy Rating LLY	03:11pm	MT
Eli Lilly: FDA approves Kisinla for Alzheimer's disease LLY	03:10pm	CF
Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients with COPD REGN	10:30am	GL
Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients with COPD REGN	10:30am	AQ
Eli Lilly Receives US Approval for Early Alzheimer's Treatment LLY	10:08am	MT
US President Calls Out Eli Lilly, Novo Nordisk Over High Drug Prices LLY	09:27am	MT
Tesla, Archer Aviation rise; Eli Lilly falls, Tuesday, 7/2/2024 LLY	03/07	AQ
Regeneron Pharmaceuticals Insider Sold Shares Worth $1,190,564, According to a Recent SEC Filing REGN	03/07	MT
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) ATXS	03/07	BU